TechNavio's analysts forecast the Global Molecular Diagnostics market to grow at a CAGR of 11.42 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing investments in genomics and proteomics research. The Global Molecular Diagnostics market has also been witnessing a growth in the diagnostics segment. However, the compliance with regulatory requirements could pose a challenge to the growth of this market.... Research Beam Model: Research Beam Product ID: 16531 2500 USD New
Global Molecular Diagnostics Market 2012-2016
 
 

Global Molecular Diagnostics Market 2012-2016

  • Category : Healthcare
  • Published On : May   2013
  • Pages : 55
  • Publisher : Technavio
 
 
 

TechNavio's analysts forecast the Global Molecular Diagnostics market to grow at a CAGR of 11.42 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing investments in genomics and proteomics research. The Global Molecular Diagnostics market has also been witnessing a growth in the diagnostics segment. However, the compliance with regulatory requirements could pose a challenge to the growth of this market. 



Exhibit 1:  Global Molecular Diagnostics Market Segmentation

TechNavio's report, the Global Molecular Diagnostics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC regions; it also covers the market segmentation based on product types, based on application, and based on technology and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.



Key vendors dominating this space include Abbott Laboratories, Becton, Dickinson and Co., QIAGEN N.V., and Roche Holding Ltd.



Other vendors mentioned in the report are Affymetrix Inc., Agilent Technologies Inc., Alere Inc., AmniSure International LLC, Anadys Pharmaceuticals Inc., Bayer HealthCare AG, Biocartis SA, bioMerieux SA, Bio-Rad Laboratories Inc., Biotest AG, Carmel Pharma AB, Celera Diagnostics LLC, Cellestis Ltd., Cepheid Inc., Cytometers Inc., Danaher Corp., Diagenode SA, Eli Lilly and Co., Eurogentec S.A., Evotec AG, GE Healthcare Ltd., Genomic Health Inc., Gen-Probe Inc., Illumina Inc., Instrumentation Laboratory Co., IRIS International Inc., Janssen Biotech Inc., KIESTRA Lab Automation BV, Life Technologies Corp., Luminex Corp., Merck & Co. Inc., mtm laboratories AG, Nanosphere Inc., Novartis AG, PerkinElmer Inc., Pharmacyclics Inc., PVT Probenverteiltechnik GmbH, Quest Diagnostics Inc., Quidel Corp., Safety Syringes Inc., SANYO North America Corp., Siemens Healthcare, Sirigen Group Limited, St. Jude Medical Inc., Sysmex Corp., and Thermo Fisher Scientific Inc.



Key questions answered in this report:

What will the market size be in 2015 and at what will be the growth rate?

What are key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by key vendors?

What are the strengths and weaknesses of each of these key vendors?



You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.


1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology


4.1.1. Market Research Process

4.1.2. Research Design

4.1.3. Research Methodology

5. Scope of the Report

Market Overview

Product Offerings

6. Market Landscape

6.1. Market Size and Forecast

6.2. Market Segmentation Based on Product Type

6.3. Market Segmentation Based on Application

6.4. Market Segmentation Based on Technology

6.5. Five Force Analysis

7. Geographical Segmentation

8. Vendor Landscape

9. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis


15.1. Abbott Laboratories

15.1.1. Business Overview

15.1.2. Key Information

15.1.3. SWOT Analysis

15.2. Becton, Dickinson and Co.

15.2.1. Business Overview

15.2.2. Key Information

15.2.3. SWOT Analysis

15.3. QIAGEN N.V. 

15.3.1. Business Overview

15.3.2. Key Information

15.3.3. SWOT Analysis

15.4. Roche Holding Ltd.

15.4.1. Business Overview

15.4.2. Key Information

15.4.3. SWOT Analysis

16. Other Reports in this Series

List of Exhibits:


Exhibit 1: Market Research Methodology

Exhibit 2: Global Molecular Diagnostics Market 2012-2016 (US$ billion)

Exhibit 3: Global Molecular Diagnostics Market Segmentation

Exhibit 4: Global Molecular Diagnostics Market Segmentation Based on Application

Exhibit 5: Global Molecular Diagnostics Market Segmentation Based on Application 2012

Exhibit 6: Global Molecular Diagnostics Market Segmentation Based on Technology

Exhibit 7: Global Molecular Diagnostics Market Segmentation Based on Technology 2012

Exhibit 8: Global Molecular Diagnostics Market by Geographical Segmentation 2012

Exhibit 9: Global Molecular Diagnostics Market by Vendor Segmentation 2012

Exhibit 10: Key Mergers and Acquisitions in the Global Molecular Diagnostics Market

Exhibit 11: Business Segmentation of Abbott Laboratories

Exhibit 12: Business Segmentation of Becton, Dickinson and Co.

Exhibit 13: Business Segmentation of QIAGEN N.V.

Exhibit 14: Business Segmentation of Roche Holding Ltd.



PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

REQUEST SAMPLE    ASK FOR DISCOUNT